Delineating the Hemostaseome as an aid to individualize the analysis of the hereditary basis of thrombotic and bleeding disorders

Human Genetics

Volumn 130, Issue 1, 2011, Pages 149-166

  Fechtel, Kim ^a   Osterbur, Marika L ^a   Kehrer Sawatzki, Hildegard ^b   Stenson, Peter D ^c   Cooper, David N ^c  

^a 3rd Millennium Inc   (United States)

^b UNIVERSITY OF ULM   (Germany)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BLEEDING; COPY NUMBER VARIATION; DNA SEQUENCE; GENE; GENE MUTATION; GENETIC VARIABILITY; GENOME ANALYSIS; HEMOSTASIS; HERITABILITY; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

BLOOD COAGULATION DISORDERS, INHERITED; DNA COPY NUMBER VARIATIONS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, HUMAN; HEMOSTASIS; HUMANS; MUTATION; SEQUENCE ANALYSIS, DNA; SOFTWARE;

EID: 79959975124     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-011-0984-y     Document Type: Review

References (89)

1. ACOG Committee Opinion (2009) ACOG Committee Opinion no. 451: Von Willebrand disease in women. Obstet Gynecol 114:1439-1443. doi: 10.1097/AOG.0b013e3181c6f975
2. Arellano AR, Bezemer ID, Tong CH, Catanese JJ, Devlin JJ, Reitsma PH, Bare LA, Rosendaal FR (2010) Gene variants associated with venous thrombosis: confirmation in the MEGA study. J Thromb Haemost 8:1132-1134. doi: 10.1111/j.1538-7836.2010.03782.x
3. E Asatiani CM Kessler 2007 Multiple congenital coagulopathies co-expressed with von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature Haemophilia 13 685 696 10.1111/j.1365-2516.2007.01541.x 17973844 10.1111/j.1365-2516.2007. 01541.x 1:STN:280:DC%2BD2snkvFahug%3D%3D (Pubitemid 350018257)
4. EA Ashley AJ Butte MT Wheeler R Chen TE Klein FE Dewey JT Dudley KE Ormond A Pavlovic AA Morgan D Pushkarev NF Neff L Hudgins L Gong LM Hodges DS Berlin CF Thorn K Sangkuhl JM Hebert M Woon H Sagreiya R Whaley JW Knowles MF Chou JV Thakuria AM Rosenbaum AW Zaranek GM Church HT Greely SR Quake RB Altman 2010 Clinical assessment incorporating a personal genome Lancet 375 1525 1535 10.1016/S0140-6736(10)60452-7 20435227 10.1016/S0140-6736(10)60452-7 1:CAS:528:DC%2BC3cXlsVOnt74%3D
5. J Astermark L Tengborn U Hedner E Berntorp 2001 Anti- and procoagulant activities in factor VII-deficient subjects Thromb Res 101 435 440 11323000 10.1016/S0049-3848(00)00410-2 1:CAS:528:DC%2BD3MXivFartr0%3D (Pubitemid 32367919)
6. J Astermark S Lacroix-Desmazes MT Reding 2008 Inhibitor development Haemophilia 14 Suppl 3 36 42 10.1111/j.1365-2516.2008.01711.x 18510520 10.1111/j.1365-2516.2008.01711.x 1:CAS:528:DC%2BD1cXps1Gls70%3D (Pubitemid 351722381)
7. Austin H, De Staercke C, Lally C, Bezemer ID, Rosendaal FR, Craig Hooper W (2011) New gene variants associated with venous thrombosis-a replication study in United States whites and blacks. J Thromb Haemost 9:489-495. doi: 10.1111/j.1538-7836.2011.04185.x
8. JS Beckmann AJ Sharp SE Antonarakis 2008 CNVs and genetic medicine (excitement and consequences of a rediscovery) Cytogenet Genome Res 123 7 16 10.1159/000184687 19287134 10.1159/000184687 1:STN:280:DC%2BD1M3gvFaqsA%3D%3D
9. LP Berg D Varon U Martinowitz K Wieland VV Kakkar DN Cooper 1994 Combined factor VIII/factor XI deficiency may cause intra-familial clinical variability in haemophilia A among Ashkenazi Jews Blood Coagul Fibrinolysis 5 59 62 8180339 10.1097/00001721-199402000-00009 1:STN:280:DyaK2c3jsFyjtw%3D%3D (Pubitemid 24091323)
10. F Bernardi C Legnani F Micheletti B Lunghi P Ferraresi G Palareti R Biagi G Marchetti 1996 A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects Thromb Haemost 76 505 509 8902986 1:CAS:528:DyaK28XmsFaqu7c%3D (Pubitemid 26372001)
11. RM Bertina BP Koeleman T Koster FR Rosendaal RJ Dirven H de Ronde PA van der Velden PH Reitsma 1994 Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 64 67 10.1038/369064a0 8164741 10.1038/369064a0 1:CAS:528:DyaK2cXktVKnt7c%3D (Pubitemid 24144355)
12. TN Bongers EL de Bruijne DW Dippel AJ de Jong JW Deckers D Poldermans MP de Maat FW Leebeek 2009 Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients Atherosclerosis 207 250 254 10.1016/j.atherosclerosis.2009.04.013 19439298 10.1016/j.atherosclerosis.2009. 04.013 1:CAS:528:DC%2BD1MXhtlyrur7I
13. SJ Bowne LS Sullivan DC Koboldt L Ding R Fulton RM Abbott EJ Sodergren DG Birch DH Wheaton JR Heckenlively Q Liu EA Pierce GM Weinstock SP Daiger 2011 Identification of disease-causing mutations in autosomal dominant retinitis pigmentosa (adRP) using next-generation DNA sequencing Invest Ophthalmol Vis Sci 52 494 503 10.1167/iovs.10-6180 20861475 10.1167/iovs.10-6180 1:CAS:528:DC%2BC3MXmsVShtr0%3D
14. G Castaman EM Faioni A Tosetto F Bernardi 2003 The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis Haematologica 88 1182 1189 14555316 (Pubitemid 37362552)
15. SC Christiansen WM Lijfering FM Helmerhorst FR Rosendaal SC Cannegieter 2010 Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event J Thromb Haemost 8 2159 2168 10.1111/j.1538-7836.2010.03994.x 20738758 10.1111/j.1538-7836.2010.03994.x 1:STN:280:DC%2BC3cbis1Wrsw%3D%3D
16. Clarke AJ, Cooper DN (2010) GWAS: heritability missing in action? Eur J Hum Genet 18:859-861. doi: 10.1038/ejhg.2010.35
17. R Clarke JF Peden JC Hopewell T Kyriakou A Goel SC Heath S Parish S Barlera MG Franzosi S Rust D Bennett A Silveira A Malarstig FR Green M Lathrop B Gigante K Leander U de Faire U Seedorf A Hamsten R Collins H Watkins M Farrall 2009 Genetic variants associated with Lp(a) lipoprotein level and coronary disease N Engl J Med 361 2518 2528 10.1056/NEJMoa0902604 20032323 10.1056/NEJMoa0902604 1:CAS:528:DC%2BC3cXls1Gg
18. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, Aerts J, Andrews TD, Barnes C, Campbell P, Fitzgerald T, Hu M, Ihm CH, Kristiansson K, Macarthur DG, Macdonald JR, Onyiah I, Pang AW, Robson S, Stirrups K, Valsesia A, Walter K, Wei J, Tyler-Smith C, Carter NP, Lee C, Scherer SW, Hurles ME (2010) Origins and functional impact of copy number variation in the human genome. Nature 464:704-712. doi: 10.1038/nature08516
19. DN Cooper JM Chen EV Ball K Howells M Mort AD Phillips N Chuzhanova M Krawczak H Kehrer-Sawatzki PD Stenson 2010 Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics Hum Mutat 31 631 655 10.1002/humu.21260 20506564 10.1002/humu.21260 1:CAS:528:DC%2BC3cXosl2lu74%3D
20. J Corral I Zuazu-Jausoro J Rivera R Gonzalez-Conejero F Ferrer V Vicente 1999 Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family Br J Haematol 105 560 563 10233438 10.1111/j.1365-2141.1999.01362.x 1:STN:280:DyaK1M3mvVyqsQ%3D%3D (Pubitemid 29232188)
21. AK Daly 2009 Pharmacogenomics of anticoagulants: steps toward personal dosage Genome Med 1 10 10.1186/gm10 19348697 10.1186/gm10
22. AJ de Smith RG Walters P Froguel AI Blakemore 2008 Human genes involved in copy number variation: mechanisms of origin, functional effects and implications for disease Cytogenet Genome Res 123 17 26 10.1159/000184688 19287135 10.1159/000184688
23. V De Stefano B Zappacosta S Persichilli E Rossi I Casorelli K Paciaroni P Chiusolo AM Leone B Giardina G Leone 1999 Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease Br J Haematol 106 564 568 10460623 10.1046/j.1365-2141.1999.01613.x (Pubitemid 29450689)
24. J Douketis A Tosetto M Marcucci T Baglin M Cushman S Eichinger G Palareti D Poli RC Tait A Iorio 2010 Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of d-dimer testing to assess recurrence risk after unprovoked venous thromboembolism Ann Intern Med 153 523 531 10.1059/0003-4819-153-8-201010190-00009 20956709
25. EE Eichler J Flint G Gibson A Kong SM Leal JH Moore JH Nadeau 2010 Missing heritability and strategies for finding the underlying causes of complex disease Nat Rev Genet 11 446 450 10.1038/nrg2809 20479774 10.1038/nrg2809 1:CAS:528:DC%2BC3cXmtFCjt78%3D
26. RS Epstein TP Moyer DJ O'Kane RE Aubert F Xia RR Verbrugge BF Gage JR Teagarden 2010 Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study) J Am Coll Cardiol 55 2804 2812 10.1016/j.jacc.2010.03.009 20381283 10.1016/j.jacc.2010.03.009 1:CAS:528:DC%2BC3cXps1ansLo%3D
27. CJ Formstone PJ Hallam EG Tuddenham J Voke M Layton K Nicolaides IM Hann DN Cooper 1996 Severe perinatal thrombosis in double and triple heterozygous offspring of a family segregating two independent protein S mutations and a protein C mutation Blood 87 3731 3737 8611698 1:CAS:528:DyaK28Xis1Sjtrc%3D (Pubitemid 26129601)
28. S Gandrille JS Greengard M Alhenc-Gelas I Juhan-Vague JF Abgrall B Jude JH Griffin M Aiach 1995 Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM Blood 86 219 224 7795227 1:CAS:528:DyaK2MXmsVOku78%3D
29. D Gemmati ML Serino S Moratelli R Mari G Ballerini GL Scapoli 1998 Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family Blood Coagul Fibrinolysis 9 173 176 9622215 10.1097/00001721-199803000-00008 1:STN:280:DyaK1c3otlGmug%3D%3D (Pubitemid 28216262)
30. K Ghosh S Shetty D Mohanty 2001 Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one-stage assay Haemophilia 7 9 12 11136374 10.1046/j.1365-2516.2001.00455.x 1:CAS:528:DC%2BD3MXnsFWgtLY%3D (Pubitemid 32162191)
31. Girolami A, Luzzatto G, Varvarikis C, Pellati D, Sartori R, Girolami B (2005) Main clinical manifestations of a bleeding diathesis: an often disregarded aspect of medical and surgical history taking. Haemophilia 11:193-202. doi: 10.1111/j.1365-2516.2005.01100.x (Pubitemid 40723793)
32. Girolami A, Tezza F, Scandellari R, Vettore S, Girolami B (2010) Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature. J Thromb Thrombolysis 30:172-178. doi: 10.1007/s11239-009-0435-y
33. R Gohil G Peck P Sharma 2009 The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls Thromb Haemost 102 360 370 10.1160/TH09-01-0013 19652888 1:CAS:528:DC%2BD1MXhtVGhsLvJ
34. AJ Gonzalez Ordonez LM Sanchez JM Medina Rodriguez MA Martinez Muniz JL Menendez Caro MV Alvarez 1999 Double carriers of the factor V Leiden and prothrombin (FIIG20210A) mutations: a description of four cases Haematologica 84 1054 1056 10553174 1:STN:280:DC%2BD3c%2FitFOmug%3D%3D
35. Gonzalez CM, Diaz-Golpe V, Martin S, Sanchez Del Real J, Redondo MC (2003) Combination of congenital coagulation disorders: factor II gene mutation G20210A, factor V Leiden gene mutation G1691A and protein S deficiency. A family study. Haematologica 88:ECR20
36. M Heinig E Petretto C Wallace L Bottolo M Rotival H Lu Y Li R Sarwar SR Langley A Bauerfeind O Hummel YA Lee S Paskas C Rintisch K Saar J Cooper R Buchan EE Gray JG Cyster J Erdmann C Hengstenberg S Maouche WH Ouwehand CM Rice NJ Samani H Schunkert AH Goodall H Schulz HG Roider M Vingron S Blankenberg T Munzel T Zeller S Szymczak A Ziegler L Tiret DJ Smyth M Pravenec TJ Aitman F Cambien D Clayton JA Todd N Hubner SA Cook 2010 A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk Nature 467 460 464 10.1038/nature09386 20827270 10.1038/nature09386 1:CAS:528:DC%2BC3cXhtFaqur7E
37. A Iorio C Kearon E Filippucci M Marcucci A Macura V Pengo S Siragusa G Palareti 2010 Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review Arch Intern Med 170 1710 1716 10.1001/archinternmed.2010.367 20975016 10.1001/archinternmed.2010.367
38. GR Jayandharan SC Nair PM Poonnoose R Thomas J John SK Keshav RS Cherian M Devadarishini KM Lakshmi RV Shaji A Viswabandya B George V Mathews M Chandy A Srivastava 2009 Polymorphism in factor VII gene modifies phenotype of severe haemophilia Haemophilia 15 1228 1236 10.1111/j.1365-2516.2009.02080.x 19686262 10.1111/j.1365-2516.2009.02080.x 1:CAS:528:DC%2BD1MXhsFGmsbzI
39. Kamstrup PR (2010) Lipoprotein(a) and ischemic heart disease-A causal association? A review. Atherosclerosis. doi: 10.1016/j.atherosclerosis.2009.12. 036
40. R Katz D Shani 2005 A case of deep vein thrombosis in patient with Hermansky-Pudlak syndrome Ann Hematol 84 763 10.1007/s00277-005-1081-x 16044314 10.1007/s00277-005-1081-x (Pubitemid 41447814)
41. BP Koeleman PH Reitsma CF Allaart RM Bertina 1994 Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families Blood 84 1031 1035 8049422 1:STN:280:DyaK2czisFGnsA%3D%3D (Pubitemid 24245865)
42. BP Koeleman D van Rumpt K Hamulyak PH Reitsma RM Bertina 1995 Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemost 74 580 583 8584987 1:CAS:528:DyaK2MXnvFKqtL0%3D
43. IS Kohane DR Masys RB Altman 2006 The incidentalome: a threat to genomic medicine JAMA 296 212 215 10.1001/jama.296.2.212 16835427 10.1001/jama.296.2.212 1:CAS:528:DC%2BD28XmvFehs7w%3D (Pubitemid 44050375)
44. A Koren C Levin Y Hujirat R El-Hasid M Kutai N Lanir S Shalev B Brenner 2003 Thrombophilia in infancy: factor V Leiden and MTHFR or factor II double heterozygocity as a risk factor Pediatr Hematol Oncol 20 219 227 12637218 1:CAS:528:DC%2BD3sXitVCmtLo%3D (Pubitemid 36460200)
45. HG Kraft A Lingenhel S Kochl F Hoppichler F Kronenberg A Abe V Muhlberger D Schonitzer G Utermann 1996 Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease Arterioscler Thromb Vasc Biol 16 713 719 8640397 10.1161/01.ATV.16.6.713 1:STN:280:DyaK283jslOqtA%3D%3D (Pubitemid 26179358)
46. E Lalonde S Albrecht KC Ha K Jacob N Bolduc C Polychronakos P Dechelotte J Majewski N Jabado 2010 Unexpected allelic heterogeneity and spectrum of mutations in Fowler syndrome revealed by next-generation exome sequencing Hum Mutat 31 918 923 10.1002/humu.21293 20518025 10.1002/humu.21293 1:CAS:528:DC%2BC3cXhtFSmsL%2FK
47. DA Lane K Auberger H Ireland AA Roscher SL Thein 1996 Prenatal diagnosis in combined antithrombin and factor V gene mutation Br J Haematol 94 753 755 8826905 10.1046/j.1365-2141.1996.02347.x 1:STN:280:DyaK28visVersA%3D%3D (Pubitemid 26308914)
48. H Lango Allen K Estrada G Lettre SI Berndt MN Weedon F Rivadeneira CJ Willer AU Jackson S Vedantam S Raychaudhuri T Ferreira AR Wood RJ Weyant AV Segre EK Speliotes E Wheeler N Soranzo JH Park J Yang D Gudbjartsson NL Heard-Costa JC Randall L Qi A Vernon Smith R Magi T Pastinen L Liang IM Heid J Luan G Thorleifsson TW Winkler ME Goddard K Sin Lo C Palmer T Workalemahu YS Aulchenko A Johansson M Carola Zillikens MF Feitosa T Esko T Johnson S Ketkar P Kraft M Mangino I Prokopenko D Absher E Albrecht F Ernst NL Glazer C Hayward JJ Hottenga KB Jacobs JW Knowles Z Kutalik KL Monda O Polasek M Preuss NW Rayner NR Robertson V Steinthorsdottir JP Tyrer BF Voight F Wiklund J Xu J Hua Zhao DR Nyholt N Pellikka M Perola JR Perry I Surakka ML Tammesoo EL Altmaier N Amin T Aspelund T Bhangale G Boucher DI Chasman C Chen L Coin MN Cooper AL Dixon Q Gibson E Grundberg K Hao M Juhani Junttila LM Kaplan J Kettunen IR Konig T Kwan RW Lawrence DF Levinson M Lorentzon B McKnight AP Morris M Muller J Suh Ngwa S Purcell S Rafelt RM Salem E Salvi, et al. 2010 Hundreds of variants clustered in genomic loci and biological pathways affect human height Nature 467 832 838 10.1038/nature09410 20881960 10.1038/nature09410 1:CAS:528:DC%2BC3cXht1ajtbfF
49. G Larciprete F Rossi T Deaibess L Brienza G Barbati E Romanini S Gioia E Cirese 2010 Double inherited thrombophilias and adverse pregnancy outcomes: fashion or science? J Obstet Gynaecol Res 36 996 1002 10.1111/j.1447-0756.2010. 01262.x 20868443 10.1111/j.1447-0756.2010.01262.x
50. Lee C, Scherer SW (2010) The clinical context of copy number variation in the human genome. Expert Rev Mol Med 12:e8. doi: 10.1017/S1462399410001390
51. S Levy G Sutton PC Ng L Feuk AL Halpern BP Walenz N Axelrod J Huang EF Kirkness G Denisov Y Lin JR MacDonald AW Pang M Shago TB Stockwell A Tsiamouri V Bafna V Bansal SA Kravitz DA Busam KY Beeson TC McIntosh KA Remington JF Abril J Gill J Borman YH Rogers ME Frazier SW Scherer RL Strausberg JC Venter 2007 The diploid genome sequence of an individual human PLoS Biol 5 e254 10.1371/journal.pbio.0050254 17803354 10.1371/journal.pbio.0050254 (Pubitemid 350035416)
52. WM Lijfering S Middeldorp NJ Veeger K Hamulyak MH Prins HR Buller J van der Meer 2010 Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A Circulation 121 1706 1712 10.1161/CIRCULATIONAHA.109.906347 20368522 10.1161/CIRCULATIONAHA.109.906347 1:CAS:528:DC%2BC3cXkvV2qtbk%3D
53. WW Lockwood R Chari BP Coe L Girard C Macaulay S Lam AF Gazdar JD Minna WL Lam 2008 DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers Oncogene 27 4615 4624 10.1038/onc.2008.98 18391978 10.1038/onc.2008.98 1:CAS:528:DC%2BD1cXptFSku7c%3D
54. LA Lotta 2010 Genome-wide association studies in atherothrombosis Eur J Intern Med 21 74 78 10.1016/j.ejim.2009.11.003 20206874 10.1016/j.ejim.2009.11. 003 1:CAS:528:DC%2BC3cXivFGks7w%3D
55. Mannucci PM, Asselta R, Duga S, Guella I, Spreafico M, Lotta L, Angelica Merlini P, Peyvandi F, Kathiresan S, Ardissino D (2010) The association of factor v Leiden with myocardial infarction is replicated in 1,880 patients with premature disease. J Thromb Haemost 8:2116-2121. doi: 10.1111/j.1538-7836.2010. 03982.x
56. TA Manolio FS Collins NJ Cox DB Goldstein LA Hindorff DJ Hunter MI McCarthy EM Ramos LR Cardon A Chakravarti JH Cho AE Guttmacher A Kong L Kruglyak E Mardis CN Rotimi M Slatkin D Valle AS Whittemore M Boehnke AG Clark EE Eichler G Gibson JL Haines TF Mackay SA McCarroll PM Visscher 2009 Finding the missing heritability of complex diseases Nature 461 747 753 10.1038/nature08494 19812666 10.1038/nature08494 1:CAS:528:DC%2BD1MXht1CisbrF
57. ER Mardis 2010 The $1,000 genome, the $100,000 analysis? Genome Med 2 84 10.1186/gm205 21114804 10.1186/gm205
58. G Mariani FH Herrmann S Schulman A Batorova K Wulff D Etro A Dolce G Auerswald J Astermark JF Schved J Ingerslev F Bernardi 2003 Thrombosis in inherited factor VII deficiency J Thromb Haemost 1 2153 2158 14521598 10.1046/j.1538-7836.2003.00395.x 1:CAS:528:DC%2BD2cXktFOltb4%3D
59. SB Ng AW Bigham KJ Buckingham MC Hannibal MJ McMillin HI Gildersleeve AE Beck HK Tabor GM Cooper HC Mefford C Lee EH Turner JD Smith MJ Rieder K Yoshiura N Matsumoto T Ohta N Niikawa DA Nickerson MJ Bamshad J Shendure 2010 Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome Nat Genet 42 790 793 10.1038/ng.646 20711175 10.1038/ng.646 1:CAS:528:DC%2BC3cXhtVaisL7K
60. SB Ng KJ Buckingham C Lee AW Bigham HK Tabor KM Dent CD Huff PT Shannon EW Jabs DA Nickerson J Shendure MJ Bamshad 2010 Exome sequencing identifies the cause of a Mendelian disorder Nat Genet 42 30 35 10.1038/ng.499 19915526 10.1038/ng.499 1:CAS:528:DC%2BD1MXhsVWlsbzE
61. U Nowak-Gottl C Escuriola K Kurnik R Schobess S Horneff A Kosch W Kreuz H Pollmann 2003 Haemophilia and thrombophilia. What do we learn about combined inheritance of both genetic variations? Hamostaseologie 23 36 40 10.1267/Hamo03010036 12567198 1:STN:280:DC%2BD3s%2Fls1Wqtg%3D%3D (Pubitemid 36197307)
62. LA O'Brien PD James M Othman E Berber C Cameron CR Notley CA Hegadorn JJ Sutherland C Hough GE Rivard D O'Shaunessey D Lillicrap 2003 Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease Blood 102 549 557 10.1182/blood-2002-12-3693 12649144 10.1182/blood-2002-12-3693 (Pubitemid 36841974)
63. HG Parker BM VonHoldt P Quignon EH Margulies S Shao DS Mosher TC Spady A Elkahloun M Cargill PG Jones CL Maslen GM Acland NB Sutter K Kuroki CD Bustamante RK Wayne EA Ostrander 2009 An expressed fgf4 retrogene is associated with breed-defining chondrodysplasia in domestic dogs Science 325 995 998 10.1126/science.1173275 19608863 10.1126/science.1173275 1:CAS:528: DC%2BD1MXhtValsrjI
64. AD Paterson JM Rommens B Bharaj J Blavignac I Wong M Diamandis JS Waye GE Rivard CP Hayward 2010 Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene Blood 115 1264 1266 10.1182/blood-2009-07-233965 20007542 10.1182/blood-2009-07-233965 1:CAS:528:DC%2BC3cXisFyrtb8%3D
65. Pelak K, Shianna KV, Ge D, Maia JM, Zhu M, Smith JP, Cirulli ET, Fellay J, Dickson SP, Gumbs CE, Heinzen EL, Need AC, Ruzzo EK, Singh A, Campbell CR, Hong LK, Lornsen KA, McKenzie AM, Sobreira NL, Hoover-Fong JE, Milner JD, Ottman R, Haynes BF, Goedert JJ, Goldstein DB (2010) The characterization of twenty sequenced human genomes. PLoS Genet 6:e1001111. doi: 10.1371/journal.pgen. 1001111
66. GH Perry A Ben-Dor A Tsalenko N Sampas L Rodriguez-Revenga CW Tran A Scheffer I Steinfeld P Tsang NA Yamada HS Park JI Kim JS Seo Z Yakhini S Laderman L Bruhn C Lee 2008 The fine-scale and complex architecture of human copy-number variation Am J Hum Genet 82 685 695 10.1016/j.ajhg.2007.12.010 18304495 10.1016/j.ajhg.2007.12.010 1:CAS:528:DC%2BD1cXksVGrtbk%3D
67. MC Pintao AA Garcia D Borgel M Alhenc-Gelas CA Spek MC de Visser S Gandrille PH Reitsma 2009 Gross deletions/duplications in PROS1 are relatively common in point mutation-negative hereditary protein S deficiency Hum Genet 126 449 456 10.1007/s00439-009-0687-9 19466456 10.1007/s00439-009-0687-9 1:CAS:528:DC%2BD1MXhtFCjt7bO
68. SR Poort FR Rosendaal PH Reitsma RM Bertina 1996 A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 3698 3703 8916933 1:CAS:528:DyaK28XntVahsLg%3D (Pubitemid 26383091)
69. Rogaev EI, Grigorenko AP, Faskhutdinova G, Kittler EL, Moliaka YK (2009) Genotype analysis identifies the cause of the "royal disease". Science 326:817. doi: 10.1126/science.1180660
70. Salomon O, Steinberg DM, Zucker M, Varon D, Zivelin A, Seligsohn U (2011) Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis. Thromb Haemost 105:269-273. doi: 10.1160/TH10-05-0307
71. MM Samama M Trossaert MH Horellou I Elalamy J Conard A Deschamps 1995 Risk of thrombosis in patients homozygous for factor V Leiden Blood 86 4700 4702 8541565 1:CAS:528:DyaK2MXpvFCjsb8%3D
72. L Sansores-Garcia A Majluf-Cruz 1998 Arterial and venous thrombosis associated to combined deficiency of protein C and antithrombin III Am J Hematol 57 182 183 10.1002/(SICI)1096-8652(199802)57:2<182::AID-AJH20>3.0.CO;2-D 9462558 10.1002/(SICI)1096-8652(199802)57:2<182::AID-AJH20>3.0.CO;2-D 1:STN:280:DyaK1c7it1eqsg%3D%3D (Pubitemid 28096548)
73. EE Schadt 2009 Molecular networks as sensors and drivers of common human diseases Nature 461 218 223 10.1038/nature08454 19741703 10.1038/nature08454 1:CAS:528:DC%2BD1MXhtFSnt7jO
74. NJ Schork SS Murray KA Frazer EJ Topol 2009 Common vs. rare allele hypotheses for complex diseases Curr Opin Genet Dev 19 212 219 10.1016/j.gde.2009.04.010 19481926 10.1016/j.gde.2009.04.010 1:CAS:528:DC%2BD1MXnt1Gmur8%3D
75. B Schuster-Bockler D Conrad A Bateman 2010 Dosage sensitivity shapes the evolution of copy-number varied regions PLoS One 5 e9474 10.1371/journal.pone. 0009474 20224824 10.1371/journal.pone.0009474
76. NL Smith KM Rice T Lumley SR Heckbert BM Psaty 2009 Discovering novel risk factors for venous thrombosis: a candidate-gene approach Thromb Res 123 Suppl 4 S25 S29 10.1016/S0049-3848(09)70139-2 19303500 10.1016/S0049-3848(09) 70139-2 1:CAS:528:DC%2BD1MXjsFWqsrs%3D
77. NL Smith KL Wiggins AP Reiner LA Lange M Cushman SR Heckbert T Lumley KM Rice AR Folsom BM Psaty 2009 Replication of findings on the association of genetic variation in 24 hemostasis genes and risk of incident venous thrombosis J Thromb Haemost 7 1743 1746 10.1111/j.1538-7836.2009.03567.x 19682239 10.1111/j.1538-7836.2009.03567.x 1:CAS:528:DC%2BD1MXhtlGnsb%2FF
78. F Sofi F Cesari R Abbate GF Gensini GJ Broze Jr S Fedi 2010 A meta-analysis of potential risks of low levels of protein Z for diseases related to vascular thrombosis Thromb Haemost 103 749 756 10.1160/TH09-09-0645 20076855 10.1160/TH09-09-0645 1:CAS:528:DC%2BC3cXls1agu7g%3D
79. BE Stranger MS Forrest M Dunning CE Ingle C Beazley N Thorne R Redon CP Bird A de Grassi C Lee C Tyler-Smith N Carter SW Scherer S Tavare P Deloukas ME Hurles ET Dermitzakis 2007 Relative impact of nucleotide and copy number variation on gene expression phenotypes Science 315 848 853 10.1126/science. 1136678 17289997 10.1126/science.1136678 1:CAS:528:DC%2BD2sXhsVShs7Y%3D
80. I Tirado J Mateo JM Soria A Oliver M Borrell I Coll C Vallve JC Souto E Martinez-Sanchez J Fontcuberta 2001 Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies Haematologica 86 1200 1208 11694407 1:CAS:528:DC%2BD38XisFanuw%3D%3D (Pubitemid 33063867)
81. U.S. Preventive Services Task Force (2009b) Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 150:396-404
82. YY van der Hoek ME Wittekoek U Beisiegel JJ Kastelein ML Koschinsky 1993 The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms Hum Mol Genet 2 361 366 8389224 10.1093/hmg/2.4.361 (Pubitemid 23107209)
83. PS Wells JL Anderson DK Scarvelis SP Doucette F Gagnon 2006 Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis Am J Epidemiol 164 101 109 10.1093/aje/kwj179 16740590 10.1093/aje/kwj179 (Pubitemid 43992174)
84. Wolff T, Miller T, Ko S (2009) Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 150:405-410. doi: 150/6/405 [pii]
85. KK Wong RJ deLeeuw NS Dosanjh LR Kimm Z Cheng DE Horsman C MacAulay RT Ng CJ Brown EE Eichler WL Lam 2007 A comprehensive analysis of common copy-number variations in the human genome Am J Hum Genet 80 91 104 10.1086/510560 17160897 10.1086/510560 1:CAS:528:DC%2BD2sXms1CmsA%3D%3D (Pubitemid 46047653)
86. Q Yang S Kathiresan JP Lin GH Tofler CJ O'Donnell 2007 Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study BMC Med Genet 8 Suppl 1 S12 10.1186/1471-2350-8-S1-S12 17903294 10.1186/1471-2350-8-S1-S12 (Pubitemid 351958749)
87. Z Ye EH Liu JP Higgins BD Keavney GD Lowe R Collins J Danesh 2006 Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls Lancet 367 651 658 10.1016/S0140-6736(06)68263-9 16503463 10.1016/S0140-6736(06)68263-9 1:CAS:528:DC%2BD28Xhslylsbg%3D (Pubitemid 43289155)
88. G Young M Albisetti M Bonduel L Brandao A Chan F Friedrichs NA Goldenberg E Grabowski C Heller J Journeycake G Kenet A Krumpel K Kurnik A Lubetsky C Male M Manco-Johnson P Mathew P Monagle H van Ommen P Simioni P Svirin D Tormene U Nowak-Gottl 2008 Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies Circulation 118 1373 1382 10.1161/CIRCULATIONAHA.108.789008 18779442 10.1161/CIRCULATIONAHA.108.789008
89. AH Zhang J Skupsky DW Scott 2009 Factor VIII inhibitors: risk factors and methods for prevention and immune modulation Clin Rev Allergy Immunol 37 114 124 10.1007/s12016-009-8122-5 19199081 10.1007/s12016-009-8122-5